User talk:Mousumi Kandangkel

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (19:33, 30 November 2025) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 1: Line 1:
-
<Structure load='9OVR' size='350' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />
+
<Structure load='9OVR' size='350' frame='true' align='right' caption='CryoEM structure of human NBCn1 (PDB 9OVR) showing the homodimeric assembly with each protomer containing 14 transmembrane helices organized into gate and core domains.' scene='Insert optional scene name here' />
 +
 
== CryoEM and Computational Modeling Structural Insights into the pH Regulator NBCn1 ==
== CryoEM and Computational Modeling Structural Insights into the pH Regulator NBCn1 ==
-
=== Function ===
+
=== Function: Physiological Role and Cancer Dependence ===
-
NBCn1 (SLC4A7) is an electroneutral Na⁺–bicarbonate cotransporter that imports base equivalents into cells to counteract acid production and maintain intracellular pH. Overexpression and high activity of NBCn1 in breast cancer cells support sustained cytosolic alkalinization, promoting proliferation and survival in an acidic tumor microenvironment.
+
The electroneutral sodium–bicarbonate cotransporter NBCn1 (SLC4A7) functions as a critical "base loader" for cellular physiology. By importing base equivalents to neutralize metabolic acid, NBCn1 maintains intracellular pH homeostasis. In the context of pathology, NBCn1 is frequently overexpressed in breast cancer cells. Its elevated activity drives sustained cytosolic alkalinization, a condition that favors tumor proliferation and survival despite the highly acidic microenvironment typical of solid tumors.
 +
 
 +
=== Structural Architecture (PDB: 9OVR) ===
 +
 
 +
The cryoEM study resolves the full-length human NBCn1 at near-atomic resolution, providing the first definitive look at its architecture. The protein assembles as a homodimer, with each protomer containing 14 transmembrane helices organized into two distinct functional domains: a rigid gate domain that serves as a membrane scaffold and a mobile core domain that houses the ion-binding sites. The resolved structure captures the transporter in an outward-facing state, characterized by a large, solvent-accessible vestibule that opens to the extracellular space while sealing off the intracellular pathway.
-
=== Structure of NBCn1 ===
+
=== Mechanism: The Carbonate Hypothesis ===
-
The cryoEM structure of human NBCn1 (PDB: 9OVR) reveals a homodimer, with each protomer containing 14 transmembrane helices organized into a relatively rigid gate domain and a mobile core domain. The solved conformation is outward-facing, showing a wide extracellular vestibule leading to a central ion-binding region consistent with Na⁺–carbonate coordination.
+
A pivotal finding of this study is the revision of the transport substrate identity. While long assumed to be a simple bicarbonate transporter, the structural and computational data argue for a Carbonate (CO₃²⁻) Symport mechanism. The density maps reveal coordination sites for two Sodium ions (2Na⁺) and one Carbonate ion (CO₃²⁻). This 2:1 stoichiometry perfectly balances the charges, resulting in net zero charge transfer consistent with NBCn1's electroneutral behavior. Transporting CO₃²⁻ is thermodynamically superior to transporting HCO₃⁻ in acidic conditions, as carbonate carries two base equivalents, achieving double the neutralizing power per transport cycle.
-
=== Mechanism of ion transport and pH regulation ===
+
=== Structural Dynamics: The "Fast Elevator" Model ===
-
CryoEM density and modeling identify binding for two Na⁺ ions and one divalent anion, supporting a predominant 2Na⁺–CO₃²⁻ electroneutral symport mode that robustly imports base even when extracellular pH is low. This stoichiometry, together with intracellular buffering, explains how NBCn1 drives powerful net acid extrusion in breast cancer cells.
+
Molecular Dynamics simulations elucidate an Elevator-Type Alternating Access Mechanism. Unlike rocker-switch transporters, NBCn1 functions like an elevator where the core domain slides vertically through the membrane plane against the static gate domain. The vertical shift required to transition between outward-facing and inward-facing states is remarkably small—approximately 5 Å. This minimal structural rearrangement implies a flat free-energy landscape with very low activation barriers, which explains the exceptionally high turnover rate of approximately 15,000 s⁻¹. NBCn1 is built for speed, functioning almost as fast as an ion channel while maintaining strict transporter coupling.
-
=== Structural insights from cryoEM and modeling ===
+
=== Biological and Medical Implications ===
-
Molecular dynamics and free‑energy calculations support an elevator-type alternating access mechanism in which the core domain carrying the binding site shifts vertically by only about 5 Å relative to the gate domain. The small, well-coordinated movement creates alternating extracellular and intracellular access with low energy barriers, enabling an unusually high turnover rate of roughly 15,000 transport cycles per second.
+
Structure-guided cysteine-scanning mutagenesis confirmed that residues lining the predicted translocation pathway are essential, with modifications abolishing transport and validating the elevator interface. Current inhibitors of acid-base transporters are often non-specific, but the unique structure of the NBCn1 extracellular vestibule provides a specific pocket for drug design. Because breast cancer cells are "addicted" to NBCn1 for pH survival while normal cells have redundant mechanisms, high-affinity inhibitors or monoclonal antibodies that lock the elevator in a single conformation could suffocate tumors by allowing lethal cytosolic acidification.
-
=== Biological and medical implications ===
+
=== Key Findings Summary ===
-
Structure‑guided cysteine scanning and mutagenesis of coordinating and pathway‑lining residues markedly reduce transport, directly linking specific structural elements to function. These maps, together with anti‑NBCn1 antibodies that block net acid extrusion and slow tumor growth, highlight NBCn1 as a promising, structurally tractable drug target in breast cancer.
+
This research transforms NBCn1 from a kinetic concept into a defined structural machine. It demonstrates that NBCn1 is a high-velocity, carbonate-preferring elevator transporter. By utilizing a compact 5 Å vertical slide, it achieves rapid base influx necessary to sustain aggressive breast cancer metabolism. The structure (PDB 9OVR) now serves as a template for structure-based drug discovery aimed at disrupting tumor pH regulation.
-
=== Key findings summary ===
+
===Course code : BI3323 ===
-
The NBCn1 structure shows how a dimeric 14‑TM elevator transporter can move large base fluxes through a compact, low‑motion ion‑binding core optimized for speed. By connecting architecture, transport stoichiometry, and tumor pH control, the study provides a detailed blueprint for designing inhibitors that selectively disable NBCn1‑mediated pH regulation in cancer cells.
+

Current revision

CryoEM structure of human NBCn1 (PDB 9OVR) showing the homodimeric assembly with each protomer containing 14 transmembrane helices organized into gate and core domains.

Drag the structure with the mouse to rotate

Contents

CryoEM and Computational Modeling Structural Insights into the pH Regulator NBCn1

Function: Physiological Role and Cancer Dependence

The electroneutral sodium–bicarbonate cotransporter NBCn1 (SLC4A7) functions as a critical "base loader" for cellular physiology. By importing base equivalents to neutralize metabolic acid, NBCn1 maintains intracellular pH homeostasis. In the context of pathology, NBCn1 is frequently overexpressed in breast cancer cells. Its elevated activity drives sustained cytosolic alkalinization, a condition that favors tumor proliferation and survival despite the highly acidic microenvironment typical of solid tumors.

Structural Architecture (PDB: 9OVR)

The cryoEM study resolves the full-length human NBCn1 at near-atomic resolution, providing the first definitive look at its architecture. The protein assembles as a homodimer, with each protomer containing 14 transmembrane helices organized into two distinct functional domains: a rigid gate domain that serves as a membrane scaffold and a mobile core domain that houses the ion-binding sites. The resolved structure captures the transporter in an outward-facing state, characterized by a large, solvent-accessible vestibule that opens to the extracellular space while sealing off the intracellular pathway.

Mechanism: The Carbonate Hypothesis

A pivotal finding of this study is the revision of the transport substrate identity. While long assumed to be a simple bicarbonate transporter, the structural and computational data argue for a Carbonate (CO₃²⁻) Symport mechanism. The density maps reveal coordination sites for two Sodium ions (2Na⁺) and one Carbonate ion (CO₃²⁻). This 2:1 stoichiometry perfectly balances the charges, resulting in net zero charge transfer consistent with NBCn1's electroneutral behavior. Transporting CO₃²⁻ is thermodynamically superior to transporting HCO₃⁻ in acidic conditions, as carbonate carries two base equivalents, achieving double the neutralizing power per transport cycle.

Structural Dynamics: The "Fast Elevator" Model

Molecular Dynamics simulations elucidate an Elevator-Type Alternating Access Mechanism. Unlike rocker-switch transporters, NBCn1 functions like an elevator where the core domain slides vertically through the membrane plane against the static gate domain. The vertical shift required to transition between outward-facing and inward-facing states is remarkably small—approximately 5 Å. This minimal structural rearrangement implies a flat free-energy landscape with very low activation barriers, which explains the exceptionally high turnover rate of approximately 15,000 s⁻¹. NBCn1 is built for speed, functioning almost as fast as an ion channel while maintaining strict transporter coupling.

Biological and Medical Implications

Structure-guided cysteine-scanning mutagenesis confirmed that residues lining the predicted translocation pathway are essential, with modifications abolishing transport and validating the elevator interface. Current inhibitors of acid-base transporters are often non-specific, but the unique structure of the NBCn1 extracellular vestibule provides a specific pocket for drug design. Because breast cancer cells are "addicted" to NBCn1 for pH survival while normal cells have redundant mechanisms, high-affinity inhibitors or monoclonal antibodies that lock the elevator in a single conformation could suffocate tumors by allowing lethal cytosolic acidification.

Key Findings Summary

This research transforms NBCn1 from a kinetic concept into a defined structural machine. It demonstrates that NBCn1 is a high-velocity, carbonate-preferring elevator transporter. By utilizing a compact 5 Å vertical slide, it achieves rapid base influx necessary to sustain aggressive breast cancer metabolism. The structure (PDB 9OVR) now serves as a template for structure-based drug discovery aimed at disrupting tumor pH regulation.

Course code : BI3323

Personal tools